Search Results - Addeo, Alfredo

Refine Results
  1. 1
    Intrathecal Methotrexate and Craniospinal Radiotherapy Can Be an Effective Treatment of Carcinomatous Meningitis in Patients with Breast Cancer: Case Reports

    Intrathecal Methotrexate and Craniospinal Radiotherapy Can Be an Effective Treatment of Carcinomatous Meningitis in Patients with Breast Cancer: Case Reports by Meissner, Magdalena, Addeo, Alfredo

    Published 2016
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  2. 2
    First-line alectinib for ALK-positive lung cancer: is there room for further improvement?

    First-line alectinib for ALK-positive lung cancer: is there room for further improvement? by Addeo, Alfredo, Metro, Giulio

    Published 2018
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  3. 3
    Treatment with Ipilimumab: A Case Report of Complete Response in a Metastatic Malignant Melanoma Patient

    Treatment with Ipilimumab: A Case Report of Complete Response in a Metastatic Malignant Melanoma Patient by Addeo, Alfredo, Rinaldi, Ciro Roberto

    Published 2013
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  4. 4
    The crucial role of predicting brain metastases development in non-small cell lung cancer patients

    The crucial role of predicting brain metastases development in non-small cell lung cancer patients by Addeo, Alfredo, Banna, Giuseppe Luigi

    Published 2018
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  5. 5
    PROS: should immunotherapy be incorporated in the treatment of oncogene-driven lung cancer?

    PROS: should immunotherapy be incorporated in the treatment of oncogene-driven lung cancer? by Addeo, Alfredo, Banna, Giuseppe Luigi

    Published 2018
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  6. 6
    PROS: should immunotherapy be incorporated in the treatment of oncogene-driven lung cancer?

    PROS: should immunotherapy be incorporated in the treatment of oncogene-driven lung cancer? by Addeo, Alfredo, Banna, Giuseppe Luigi

    Published 2018
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  7. 7
    Measuring tumor mutation burden in cell-free DNA: advantages and limits

    Measuring tumor mutation burden in cell-free DNA: advantages and limits by Addeo, Alfredo, Weiss, Glen J.

    Published 2019
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  8. 8
    The clinical fallout of organizational resilience in oncology during the pandemic

    The clinical fallout of organizational resilience in oncology during the pandemic by Addeo, Alfredo, Banna, Giuseppe L.

    Published 2022
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  9. 9
    New emerging targets in cancer immunotherapy: the role of TIM3

    New emerging targets in cancer immunotherapy: the role of TIM3 by Friedlaender, Alex, Addeo, Alfredo, Banna, Giuseppe

    Published 2019
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  10. 10
    Rethinking the Optimal Duration of Immune Checkpoint Inhibitors in Non-small Cell Lung Cancer Throughout the COVID-19 Pandemic

    Rethinking the Optimal Duration of Immune Checkpoint Inhibitors in Non-small Cell Lung Cancer Throughout the COVID-19 Pandemic by Friedlaender, Alex, Kim, Chul, Addeo, Alfredo

    Published 2020
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  11. 11
    COVID-19 and lung cancer: risks, mechanisms and treatment interactions

    COVID-19 and lung cancer: risks, mechanisms and treatment interactions by Addeo, Alfredo, Obeid, Michel, Friedlaender, Alex

    Published 2020
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  12. 12
    The Role and Impact of Minimal Residual Disease in NSCLC

    The Role and Impact of Minimal Residual Disease in NSCLC by Frisone, Daniele, Friedlaender, Alex, Addeo, Alfredo

    Published 2021
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  13. 13
    Association of Industry and Academic Sponsorship With Negative Phase 3 Oncology Trials and Reported Outcomes on Participant Survival: A Pooled Analysis

    Association of Industry and Academic Sponsorship With Negative Phase 3 Oncology Trials and Reported Outcomes on Participant Survival: A Pooled Analysis by Addeo, Alfredo, Weiss, Glen J., Gyawali, Bishal

    Published 2019
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  14. 14
    Tracking the tail

    Tracking the tail by Friedlaender, Alex, Liu, Stephen V, Addeo, Alfredo

    Published 2020
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  15. 15
    ADAURA: Mature Enough for Publication, Not for Prime Time

    ADAURA: Mature Enough for Publication, Not for Prime Time by Addeo, Alfredo, Banna, Giuseppe Luigi, Friedlaender, Alex

    Published 2020
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  16. 16
    KRAS G12C Mutations in NSCLC: From Target to Resistance

    KRAS G12C Mutations in NSCLC: From Target to Resistance by Addeo, Alfredo, Banna, Giuseppe Luigi, Friedlaender, Alex

    Published 2021
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  17. 17
    Stepping in the right direction but still some ways to go

    Stepping in the right direction but still some ways to go by Addeo, Alfredo, Banna, Giuseppe Luigi, Friedlaender, Alex

    Published 2019
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  18. 18
    One more piece to SOLIDify our knowledge on the impact of SARS-CoV-2 in patients with cancer

    One more piece to SOLIDify our knowledge on the impact of SARS-CoV-2 in patients with cancer by Addeo, Alfredo, Cortellini, Alessio, Banna, Giuseppe Luigi

    Published 2022
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  19. 19
    Learning from the past to design better trials in second-line treatment for mesothelioma patients

    Learning from the past to design better trials in second-line treatment for mesothelioma patients by Addeo, Alfredo, Banna, Giuseppe Luigi, Dietrich, Pierre-Yves

    Published 2018
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  20. 20
    The Activity of Immune Checkpoint Inhibition in KRAS Mutated Non-small Cell Lung Cancer: A Single Centre Experience

    The Activity of Immune Checkpoint Inhibition in KRAS Mutated Non-small Cell Lung Cancer: A Single Centre Experience by TORRALVO, JAVIER, FRIEDLAENDER, ALEX, ACHARD, VERANE, ADDEO, ALFREDO

    Published 2019
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:

Search Tools: